Ergoteles’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,911
| Closed | -$147K | – | 326 |
|
|
2023
Q2 | $147K | Buy |
+30,911
| New | +$147K | 0.01% | 887 |
|
|
2022
Q1 | – | Sell |
-47,026
| Closed | -$2.75M | – | 1348 |
|
|
2021
Q4 | $2.75M | Buy |
+47,026
| New | +$2.75M | 0.11% | 205 |
|
|
2021
Q3 | – | Sell |
-3,554
| Closed | -$308K | – | 1351 |
|
|
2021
Q2 | $308K | Sell |
3,554
-15,746
| -82% | -$1.36M | 0.01% | 1058 |
|
|
2021
Q1 | $1.59M | Buy |
+19,300
| New | +$1.59M | 0.05% | 313 |
|